Haiting Liu

Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

LINC00882, transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m6A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA.

LINC00882, transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m6A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA.

Journal: Oncogene
Published: December 14, 2023

NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling.

NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling.

Journal: Cell death & disease
Published: August 10, 2023

CMYC-initiated HNF1A-AS1 overexpression maintains the stemness of gastric cancer cells.

CMYC-initiated HNF1A-AS1 overexpression maintains the stemness of gastric cancer cells.

Journal: Cell death & disease
Published: May 31, 2023

Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review).

Mechanistic insights into UHRF1‑mediated DNA methylation by structure‑based functional clarification of UHRF1 domains (Review).

Journal: Oncology letters
Published: March 04, 2023

PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway.

PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway.

Journal: Cell death & disease
Published: November 21, 2022

Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer.

Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer.

Journal: Cancer research
Published: April 15, 2021

ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.

ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.

Journal: Medical oncology (Northwood, London, England)
Published: April 06, 2021

Erratum: The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum.

Erratum: The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum.

Journal: International journal of biological sciences
Published: March 26, 2021

E2F1 Induces KIF26A Transcription and Promotes Cell Cycle Progression via CDK-RB-E2Fs Feedback Loop in Breast Cancer.

E2F1 Induces KIF26A Transcription and Promotes Cell Cycle Progression via CDK-RB-E2Fs Feedback Loop in Breast Cancer.

Journal: Frontiers in oncology
Published: January 30, 2020

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.

Journal: International journal of biological sciences
Published: November 03, 2019

Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer.

Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer.

Journal: Oncogene
Published: November 27, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026